- Investopedia•4 days ago
Ziopharm's fourth quarter loss was in line with analyst estimates.
- Associated Press•5 days ago
On a per-share basis, the Boston-based company said it had a loss of 11 cents. The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•5 days ago
-Company to Webcast Corporate Update Thursday, February 23, at the 2017 RBC Global Healthcare Conference-. BOSTON, Feb. 16, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, ...
ZIOP : Summary for ZIOPHARM Oncology Inc - Yahoo Finance
ZIOPHARM Oncology, Inc. (ZIOP)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.62 x 1000|
|Ask||7.05 x 100|
|Day's Range||6.76 - 6.97|
|52 Week Range||4.45 - 9.74|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|